We are also proud to announce the
Virginia Campus will now offer a degree program from
the GW School of Medicine & Health Sciences, a goal
we have been working towards for some time. We invite you to browse information about
the program and spread the word to prospective students. Press release Program
Website
Q: What is Pharmacogenomics?
A: Pharmacogenomics is the study of how a person's genetics affect the body's
response to drugs. Genetic testing to predict drug response and then tailoring
drug therapies to individual patients is the cornerstone of this field.
Q: Why did GW and Shenandoah decide to launch this joint
program?
A: GW President Stephen Joel Trachtenberg said the two
institutions saw a clear need in the marketplace and responded with an
academic solution. The fast-growing field of pharmacogenomics is expected
to generate a market of $2 billion by the year 2006.
Q: In what ways is this program significant for the Virginia
Campus?
A: This is the first degree program being offered by the School of Medicine and
Health Sciences at the Virginia Campus. This also expands our course offerings
to include a new, unique program available only at the GW Virginia Campus.
Q: Will students and faculty for this program be at The Virginia Campus in the near future?
A: Yes, students will attend classes at the Virginia Campus starting in fall
2005. Offices will be designated for GW and Shenandoah faculty. Several laboratory
classes will be taught at the Foggy Bottom Campus, but the majority of classes
will be held at the Virginia Campus or through distance learning.
Q: An overview of the program?
A: This is an innovative, two-step program providing
students a seamless curriculum between two degrees. The student first completes
their undergraduate work by transferring into the full-time bachelor’s
degree in Health Sciences after completing at least 60 credits. They are
admitted as juniors or seniors. During the senior year students can apply
to the Doctor of Pharmacy at Shenandoah University and
be admitted into the second year of the PharmD program.
Q: Tell me about the curriculum?
A: The junior year coursework focuses on basic sciences and will be taught
by GW faculty. In the senior year, students will be taught by Shenandoah University
(SU) faculty with the curriculum that doubles for the first year of SU's Doctor
of Pharmacy (Pharm.D.) program.
Q: What degrees are awarded to students completing
both parts of the program?
A: B.S. in Health Sciences from GW (specialization in Pharmacogenomics) and
a Doctor of Pharmacy (Pharm.D.) from Shenandoah University.
Students are able to complete both the B.S. in HS and the Pharm.D. degrees
in seven years instead of eight.
Q: What kinds of career prospects will be available
to graduates of this program?
A: Northern Virginia ranks third in the
country in the number of biotechnology companies, a rapidly
growing industry. Biosciences offer high paying, quality jobs across a spectrum
of companies. Bioscience workers made $26,000 more than individuals with comparable
degrees in other industries. The bioscience work force is approximately 885,000
people; 70% work in medical devices and drugs and pharmaceuticals. The biotechnology
workforce is approximately 200,000.
Q: What does a prospective student need to apply?
A: 60 credits of coursework from a community college, college, or university
See full list of course requirements at http://www.gwumc.edu/healthsci/Programs/Pharmacogenomics/Pharmacogenomics_entrance.htm
Q: When are applications being accepted?
A: Applications are now being accepted for fall 2005. For information call
(202) 994-3373 or apply online at www.gwumc.edu/healthsci.
Q: How can I find out more about the program?
A: Browse the website at www.gwumc.edu/healthsci.
|
